Mirae Asset Global Etfs Holdings Ltd. Immunity Bio, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 138,350 shares of IBRX stock, worth $351,409. This represents 0.0% of its overall portfolio holdings.
Number of Shares
138,350
Previous 105,624
30.98%
Holding current value
$351,409
Previous $317,000
15.14%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IBRX
# of Institutions
274Shares Held
120MCall Options Held
2.5MPut Options Held
3.14M-
Vanguard Group Inc Valley Forge, PA21.8MShares$55.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$29 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC8.76MShares$22.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.76MShares$19.7 Million0.36% of portfolio
-
Jane Street Group, LLC New York, NY7.72MShares$19.6 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.02B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...